Search results
Pharmaceuticals and Medical Devices Agency. Provision of Information regarding Post-marketing Safety. Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics. Advanced Review with Electronic Data Promotion Group. Subcommittee on Evaluation of Medical Devices in Pediatric Use.
The Pharmaceuticals and Medical Devices Agency (独立行政法人医薬品医療機器総合機構, Dokuritsu-gyōsei hōjin iyakuhin-iryō-kiki-sōgō-kikō) ( PhMDA) is an Independent Administrative Institution responsible for ensuring the safety, efficacy and quality of pharmaceuticals and medical devices [1] in Japan.
For information about PMDA, please visit here. Recent Press Releases. APEC endorsed Japan’s PMDA as a pilot Training Center for Medical Devices Regulation (March 18, 2019) To protect people from drug abuse. For Travelers. Illicit Drugs[PDF:748KB] Cannabis[PDF:902KB]
The Panchkula Metropolitan Development Authority (PMDA) was established by the Haryana Act No. 23 of 2021, notification dated 09.09.2021, to develop a vision for continued, sustained, and balanced growth of the Panchkula Metropolitan Area.
3 days ago · Haryana, announced the constitution of the Panchkula Metropolitan Development Authority (PMDA) for swift execution of the region’s integrated development plan in June 2021.
[2024/03/25] ＜MD＞One Certification Criteria is published and 100 are revised. One is withdrawn.
Aug 12, 2018 · Learn about Japan medical device and pharmaceutical regulations under the Pharmaceuticals and Medical Devices Act (PMD Act), including the role of the PMDA and MHLW agencies, the regulatory approval process for devices and drugs, and the latest developments and news in the field.
Jul 18, 2024 · The PMDA will provide for integrated and coordinated planning, infrastructure development, provision of urban amenities, social, economic and industrial development of the area, better traffic management, transport infrastructure, and sustainable management of urban environment.
Mutual recognition. agreements (MRA) This content applies to human and veterinary medicines. The European Union (EU) has signed mutual recognition agreements (MRAs) with third-country authorities concerning the conformity assessment of regulated products.
Sponsors need to understand the differences precisely and consider efficient processes to meet requirements of each health authority (HA). This e-Poster illustrates about e-Submissions and focus on key differences between e-submission requirements for the FDA and PMDA.
